- Home
- CLIR vs CGTX Comparison
CLIR vs CGTX Comparison
Compare CLIR & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- CGTX
- Stock Information
- Founded
- CLIR 2008
- CGTX 2007
- Country
- CLIR United States
- CGTX United States
- Employees
- CLIR N/A
- CGTX N/A
- Industry
- CLIR Industrial Machinery/Components
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- CGTX Health Care
- Exchange
- CLIR Nasdaq
- CGTX Nasdaq
- Market Cap
- CLIR 31.2M
- CGTX 53.4M
- IPO Year
- CLIR 2012
- CGTX 2021
- Fundamental
- Price
- CLIR $0.57
- CGTX $0.62
- Analyst Decision
- CLIR Strong Buy
- CGTX Strong Buy
- Analyst Count
- CLIR 1
- CGTX 4
- Target Price
- CLIR $2.00
- CGTX $2.83
- AVG Volume (30 Days)
- CLIR 84.1K
- CGTX 20.1M
- Earning Date
- CLIR 08-13-2025
- CGTX 08-07-2025
- Dividend Yield
- CLIR N/A
- CGTX N/A
- EPS Growth
- CLIR N/A
- CGTX N/A
- EPS
- CLIR N/A
- CGTX N/A
- Revenue
- CLIR $2,895,000.00
- CGTX N/A
- Revenue This Year
- CLIR $27.61
- CGTX N/A
- Revenue Next Year
- CLIR $116.19
- CGTX N/A
- P/E Ratio
- CLIR N/A
- CGTX N/A
- Revenue Growth
- CLIR 10.88
- CGTX N/A
- 52 Week Low
- CLIR $0.46
- CGTX $0.22
- 52 Week High
- CLIR $1.72
- CGTX $1.29
- Technical
- Relative Strength Index (RSI)
- CLIR 47.77
- CGTX 52.26
- Support Level
- CLIR $0.50
- CGTX $0.62
- Resistance Level
- CLIR $0.63
- CGTX $0.87
- Average True Range (ATR)
- CLIR 0.05
- CGTX 0.09
- MACD
- CLIR 0.01
- CGTX -0.01
- Stochastic Oscillator
- CLIR 48.19
- CGTX 21.83
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.